This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Glaxosmithkline LLC. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: The Innovations of Robert Blount McFadyen
Introduction
Robert Blount McFadyen is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, McFadyen's work focuses on novel compounds that have therapeutic applications.
Latest Patents
His latest patents include innovations related to Farnesoid X receptor agonists. The present invention provides novel substituted isoxazole compounds, pharmaceutical compositions, therapeutic uses, and processes for preparing the same. This work highlights his commitment to advancing medical science through innovative solutions.
Career Highlights
McFadyen is currently associated with GlaxoSmithKline LLC, where he continues to develop groundbreaking pharmaceutical technologies. His expertise in the field has positioned him as a valuable asset to his company and the broader scientific community.
Collaborations
Some of his coworkers include David Norman Deaton and Frank Navas, III, who contribute to the collaborative environment that fosters innovation at GlaxoSmithKline.
Conclusion
Robert Blount McFadyen exemplifies the spirit of innovation in the pharmaceutical industry, with his patents paving the way for future advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile